In silico-guided sequence modifications of K-ras epitopes improve immunological outcome against G12V and G13D mutant KRAS antigens
Background: Somatic point substitution mutations in the KRAS proto-oncogene primarily affect codons 12/13 where glycine is converted into other amino acids, and are highly prevalent in pancreatic, colorectal, and non-small cell lung cancers. These cohorts are non-responsive to anti-EGFR treatments,...
Hlavní autoři: | , , , , , , , , , , , |
---|---|
Médium: | Článek |
Jazyk: | English |
Vydáno: |
PeerJ
2018
|
On-line přístup: | http://psasir.upm.edu.my/id/eprint/74613/1/In%20silico-guided%20sequence%20modifications%20of%20K-ras%20epitopes%20improve%20immunological%20outcome%20against%20G12V%20and%20G13D%20mutant%20KRAS%20antigens.pdf |